Cassady Schiller Wealth Management, LLC Neurocrine Biosciences Inc Transaction History
Cassady Schiller Wealth Management, LLC
- $268 Million
- Q4 2024
A detailed history of Cassady Schiller Wealth Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Cassady Schiller Wealth Management, LLC holds 11 shares of NBIX stock, worth $1,285. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11Holding current value
$1,285% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
647Shares Held
96.3MCall Options Held
599KPut Options Held
554K-
Black Rock Inc. New York, NY14.2MShares$1.66 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.18 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$572 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$353 Million0.26% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.49MShares$291 Million0.54% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...